Concise Review: Process Development Considerations for Cell Therapy

Stem Cells Translational Medicine
Andrew CampbellOhad Karnieli

Abstract

The development of robust and well-characterized methods of production of cell therapies has become increasingly important as therapies advance through clinical trials toward approval. A successful cell therapy will be a consistent, safe, and effective cell product, regardless of the cell type or application. Process development strategies can be developed to gain efficiency while maintaining or improving safety and quality profiles. This review presents an introduction to the process development challenges of cell therapies and describes some of the tools available to address production issues. This article will provide a summary of what should be considered to efficiently advance a cellular therapy from the research stage through clinical trials and finally toward commercialization. The identification of the basic questions that affect process development is summarized in the target product profile, and considerations for process optimization are discussed. The goal is to identify potential manufacturing concerns early in the process so they may be addressed effectively and thus increase the probability that a therapy will be successful. The present study contributes to the field of cell therapy by providing a resource for th...Continue Reading

References

Feb 6, 2009·Biotechnology Progress·Carl-Fredrik Mandenius, Anders Brundin
Aug 4, 2009·Trends in Biotechnology·Anurag S Rathore
May 19, 2010·Analytical and Bioanalytical Chemistry·A S RathoreV Ghare
Aug 12, 2010·Tissue Engineering. Part C, Methods·Hau Wan LeungSteve K W Oh
Sep 28, 2010·Regenerative Medicine·Gregory YourekGwendolen C Reilly
May 10, 2011·Regenerative Medicine·Chris MasonNatasha L Davie
Dec 16, 2011·Regenerative Medicine·David A BrindleyJon A Rowley
Oct 9, 2013·Stem Cells Translational Medicine·Shannon EakerRavenska Wagey

❮ Previous
Next ❯

Citations

Feb 26, 2016·Nature Reviews. Molecular Cell Biology·Alan Trounson, Natalie D DeWitt
Jun 28, 2016·Molecular Therapy Oncolytics·Xiuyan Wang, Isabelle Rivière
Aug 17, 2016·Journal of Biotechnology·António M de SoureJoaquim M S Cabral
Nov 6, 2015·Stem Cells Translational Medicine·Andre TerzicC Michel Harper
Mar 18, 2017·Expert Opinion on Biological Therapy·Anna BadnerMichael G Fehlings
Dec 8, 2017·Journal of Biological Engineering·Derek TomsMark Ungrin
Oct 6, 2018·Regenerative Medicine·Timothy R Olsen, Jon A Rowley
Aug 1, 2018·Biotechnology and Bioengineering·Kelvin S NgJeffrey M Karp
Mar 8, 2019·Journal of Cachexia, Sarcopenia and Muscle·Taimoor H QaziTobias Winkler
Aug 20, 2019·Protein Science : a Publication of the Protein Society·Lucie HartmannJean A Boutin
Feb 12, 2019·Nature Biomedical Engineering·Eduardo Marbán
Jun 13, 2020·Frontiers in Pharmacology·Darshana S CherianTracy S P Heng
Jul 31, 2018·Stem Cells International·Amanda Mizukami, Kamilla Swiech
Dec 12, 2020·Journal of Pharmaceutical Sciences·Dhananjay JereHanns-Christian Mahler
Dec 4, 2020·Tissue Engineering. Part C, Methods·Zhenguo WangBart Spee
Jan 6, 2021·Cell and Tissue Banking·Nazanin AndalibMaryam M Matin
Feb 18, 2021·Cytotherapy·Renske M T Ten HamJoanne C Mountford
Feb 23, 2021·Frontiers in Cardiovascular Medicine·Paloma GastelurrutiaCarolina Gálvez-Montón
Mar 23, 2021·Experimental Neurology·Jonathon Chon Teng ChioMichael G Fehlings
Mar 26, 2021·Seminars in Liver Disease·Sheeba KhanPhilip N Newsome
Mar 31, 2021·British Journal of Cancer·Matteo MorottiAhmed A Ahmed
May 15, 2021·American Society of Clinical Oncology Educational Book·Tamara J LaskowskiKatayoun Rezvani
May 25, 2021·Bioengineering & Translational Medicine·Lily Li-Wen WangSamir Mitragotri
Aug 25, 2021·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Xue Yao, Sandro Matosevic
Nov 3, 2021·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Araceli Rivera-OrdazLorenza Lazzari
Jun 28, 2019·Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie·Charles J Hunt

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.